314 related articles for article (PubMed ID: 30341286)
1. Targeting enhancer of zeste homolog 2 protects against acute kidney injury.
Zhou X; Zang X; Guan Y; Tolbert T; Zhao TC; Bayliss G; Zhuang S
Cell Death Dis; 2018 Oct; 9(11):1067. PubMed ID: 30341286
[TBL] [Abstract][Full Text] [Related]
2. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
[TBL] [Abstract][Full Text] [Related]
3. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.
Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N
J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944
[TBL] [Abstract][Full Text] [Related]
4. EZH2 plays a crucial role in ischemia/reperfusion-induced acute kidney injury by regulating p38 signaling.
Liang H; Huang Q; Liao MJ; Xu F; Zhang T; He J; Zhang L; Liu HZ
Inflamm Res; 2019 Apr; 68(4):325-336. PubMed ID: 30820607
[TBL] [Abstract][Full Text] [Related]
5. Enhancer of zeste homolog 2 modulates oxidative stress-mediated pyroptosis in vitro and in a mouse kidney ischemia-reperfusion injury model.
Liu H; Chen Z; Weng X; Chen H; Du Y; Diao C; Liu X; Wang L
FASEB J; 2020 Jan; 34(1):835-852. PubMed ID: 31914694
[TBL] [Abstract][Full Text] [Related]
6. Selective EZH2 inhibitor zld1039 alleviates inflammation in cisplatin-induced acute kidney injury partially by enhancing RKIP and suppressing NF-κB p65 pathway.
Wen L; Tao SH; Guo F; Li LZ; Yang HL; Liang Y; Zhang LD; Ma L; Fu P
Acta Pharmacol Sin; 2022 Aug; 43(8):2067-2080. PubMed ID: 34937916
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of Src kinase protects against acute kidney injury in a murine model of renal ischemia/reperfusion.
Xiong C; Zang X; Zhou X; Liu L; Masucci MV; Tang J; Li X; Liu N; Bayliss G; Zhao TC; Zhuang S
Oncotarget; 2017 May; 8(19):31238-31253. PubMed ID: 28415724
[TBL] [Abstract][Full Text] [Related]
8. Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression.
Zhou X; Zang X; Ponnusamy M; Masucci MV; Tolbert E; Gong R; Zhao TC; Liu N; Bayliss G; Dworkin LD; Zhuang S
J Am Soc Nephrol; 2016 Jul; 27(7):2092-108. PubMed ID: 26701983
[TBL] [Abstract][Full Text] [Related]
9. Multi-Omics Integrated Analysis of the Protective Effect of EZH2 Inhibition in Mice with Renal Ischemia-Reperfusion Injury.
Zou S; Chen J; Zhou P; Xue M; Wu M; Wang L
Kidney Blood Press Res; 2024; 49(1):196-207. PubMed ID: 38368866
[TBL] [Abstract][Full Text] [Related]
10. Blockade of enhancer of zeste homolog 2 alleviates renal injury associated with hyperuricemia.
Shi Y; Xu L; Tao M; Fang L; Lu J; Gu H; Ma S; Lin T; Wang Y; Bao W; Qiu A; Zhuang S; Liu N
Am J Physiol Renal Physiol; 2019 Mar; 316(3):F488-F505. PubMed ID: 30566000
[TBL] [Abstract][Full Text] [Related]
11. Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization.
Zhou X; Chen H; Hu Y; Ma X; Li J; Shi Y; Tao M; Wang Y; Zhong Q; Yan D; Zhuang S; Liu N
Cell Death Dis; 2023 Apr; 14(4):253. PubMed ID: 37029114
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of EZH2 ameliorates hyperoxaluria-induced kidney injury through the JNK/FoxO3a pathway.
Gao X; Peng Y; Fang Z; Li L; Ming S; Dong H; Li R; Zhu Y; Zhang W; Zhu B; Liao J; Wang Z; Liu M; Li W; Zeng J; Gao X
Life Sci; 2022 Feb; 291():120258. PubMed ID: 34952043
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of EZH2 alleviates angiogenesis in a model of corneal neovascularization by blocking FoxO3a-mediated oxidative stress.
Wan SS; Pan YM; Yang WJ; Rao ZQ; Yang YN
FASEB J; 2020 Aug; 34(8):10168-10181. PubMed ID: 32562311
[TBL] [Abstract][Full Text] [Related]
14. Expression and Function of Interleukin-1β-Induced Neutrophil Gelatinase-Associated Lipocalin in Renal Tubular Cells.
Konno T; Nakano R; Mamiya R; Tsuchiya H; Kitanaka T; Namba S; Kitanaka N; Okabayashi K; Narita T; Sugiya H
PLoS One; 2016; 11(11):e0166707. PubMed ID: 27851800
[TBL] [Abstract][Full Text] [Related]
15. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H
Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480
[No Abstract] [Full Text] [Related]
16. Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes.
Deb G; Shankar E; Thakur VS; Ponsky LE; Bodner DR; Fu P; Gupta S
Mol Carcinog; 2019 Jul; 58(7):1194-1207. PubMed ID: 30854739
[TBL] [Abstract][Full Text] [Related]
17. AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3.
Liebisch M; Wolf G
Am J Nephrol; 2020; 51(9):676-692. PubMed ID: 32854097
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.
Duraisamy AJ; Mishra M; Kowluru RA
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6440-6448. PubMed ID: 29261844
[TBL] [Abstract][Full Text] [Related]
19. EZH2 inhibitor DZNep modulates microglial activation and protects against ischaemic brain injury after experimental stroke.
Chen J; Zhang M; Zhang X; Fan L; Liu P; Yu L; Cao X; Qiu S; Xu Y
Eur J Pharmacol; 2019 Aug; 857():172452. PubMed ID: 31202798
[TBL] [Abstract][Full Text] [Related]
20. Tubule-specific ablation of endogenous β-catenin aggravates acute kidney injury in mice.
Zhou D; Li Y; Lin L; Zhou L; Igarashi P; Liu Y
Kidney Int; 2012 Sep; 82(5):537-47. PubMed ID: 22622501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
